Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Compugen Ltd.
  6. News
  7. Summary
    CGEN   IL0010852080

COMPUGEN LTD.

(CGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Compugen : Says AstraZeneca Will Launch Study on Lung Cancer Drug Candidate Based on Its COM902 Antibody

08/19/2021 | 08:37am EDT


ę MT Newswires 2021
All news about COMPUGEN LTD.
10/04COMPUGEN : Expects $6 Million Milestone Payment From AstraZeneca for First Patient Dosed i..
MT
10/04COMPUGEN : Announces Milestone Payment from AstraZeneca Triggered by First Patient Dosed w..
PR
10/04Compugen Ltd. Announces Milestone Payment from AstraZeneca Triggered by First Patient D..
CI
10/01COMPUGEN : To Present Clinical Data from anti-TIGIT COM902 Monotherapy and Triple Combinat..
PR
09/22COMPUGEN : Awarded Top 50 Most Promising Microsoft Solution Providers by CIOReview
AQ
09/14COMPUGEN : to Present at the Cantor Global Healthcare Conference
PU
08/26COMPUGEN : to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
PR
08/19COMPUGEN : Says AstraZeneca Will Launch Study on Lung Cancer Drug Candidate Based on Its C..
MT
08/19COMPUGEN : Announces Bispecific Antibody Derived from COM902 to Enter Clinical Development
PR
08/19Compugen Announces Bispecific Antibody Derived from COM902 to Enter Clinical Developmen..
CI
More news
Analyst Recommendations on COMPUGEN LTD.
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 -41,2 M - -
Net Debt 2021 - - -
P/E ratio 2021 -12,7x
Yield 2021 -
Capitalization 520 M 520 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 -
Nbr of Employees 68
Free-Float 99,9%
Chart COMPUGEN LTD.
Duration : Period :
Compugen Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COMPUGEN LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 6,20 $
Average target price 20,86 $
Spread / Average Target 236%
EPS Revisions
Managers and Directors
Anat Cohen-Dayag President, Chief Executive Officer & Director
Ari Krashin Chief Operating & Financial Officer
Paul Jai Sekhri Chairman
Henry Adewoye Chief Medical Officer
Arie Ovadia Director
Sector and Competitors
1st jan.Capi. (M$)
COMPUGEN LTD.-49.30%520
MODERNA, INC.234.60%141 099
LONZA GROUP AG31.93%60 646
IQVIA HOLDINGS INC.43.58%49 145
SEAGEN INC.0.22%31 933
CELLTRION, INC.-39.69%25 328